JAZZJazz Pharmaceuticals, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 17418
Ticker: JAZZ
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2007-06-01
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: JAZZ

Detail

Enriched 2026-08-14 20:47

Market cap: $16,160,159,371.27
Shares outstanding (class): 64,914,577
Shares outstanding (weighted): 64,914,577
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 2,890
Location: DUBLIN
Homepage: https://www.jazzpharmaceuticals.com
Description: Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Market cap and share counts drift.

Funds holding this security

252 funds · 261 positions · $3.34B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
American Funds Fundamental Investors American Funds Fundamental Investors	—	$397.00M	0.26%	2,100,000 NS	TICKER
iShares Core S&P Mid-Cap ETF iShares Trust	IJH	$380.35M	0.36%	2,011,886 NS	TICKER
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$351.16M	0.02%	1,857,520 NS	TICKER
FULLERTHALER BEHAVIORAL SMALL CAP EQUITY Capitol Series Trust	—	$302.70M	2.71%	1,601,163 NS	TICKER
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$254.93M	0.15%	1,348,461 NS	TICKER
VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS	VBR	$162.34M	0.27%	858,699 NS	TICKER
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$128.21M	0.16%	678,156 NS	TICKER
SMALLCAP World Fund Inc SMALLCAP World Fund Inc	—	$94.53M	0.12%	500,000 NS	TICKER
State Street SPDR S&P MidCap 400SM ETF Trust —	—	$86.58M	0.36%	457,993 NS	TICKER
JPMorgan Mid Cap Value Fund J.P. Morgan Fleming Mutual Fund Group, Inc.	—	$76.26M	0.70%	403,410 NS	TICKER
PIMCO RAE US Small Fund PIMCO Equity Series	—	$73.41M	2.34%	388,324 NS	TICKER
Franklin Dynatech Fund Franklin Custodian Funds	—	$70.89M	0.29%	375,000 NS	TICKER
iShares S&P Mid-Cap 400 Growth ETF iShares Trust	IJK	$69.88M	0.70%	369,631 NS	TICKER
State Street(R) SPDR(R) Portfolio S&P 400(TM) M… SPDR SERIES TRUST	SPMD	$56.12M	0.36%	296,842 NS	TICKER
iShares Russell Mid-Cap ETF iShares Trust	IWR	$42.28M	0.09%	223,633 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERJAZZ
CIK0001232524
ISINIE00B4Q5ZN47
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Jazz Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing pharmaceutical products.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.